Healthcare Staffing Report: Aug. 21, 2014

Print

UK pharmaceutical M&A creating demand for healthcare contractors

Increased levels of mergers and acquisitions activity in the pharmaceutical sector has led to greater demand for healthcare contractors, according to the latest research from umbrella employment provider giant group.

The company’s analysis of the healthcare market found that the number of contractors working at pharmaceutical companies increased year over year by 10 percent.

Further opportunities are predicted in the sector as 12 percent of respondents expect there to be more demand over the next 12 months, representing an increase of 7 percentage points compared with figures recorded in 2013.

Much of this activity can be attributed to the heightened levels of m&a activity in the sector over recent months. There have been 14 reported mergers and acquisitions worth more than a billion dollars in healthcare so far this year and this is driving the creation of roles for the contractor base.

Suggestions that permanent headcount at the pharmaceutical companies involved in mergers and acquisition will continue to drop has add greater credence to the belief that opportunities for contract workers will increase.

“The m&a activity is certainly behind much of the increase in roles,” said Matthew Brown, managing director of giant group. “Any time such massive strategic partnerships are undertaken there will always be opportunities for contractors and this is obviously no different. Expertise will be required to deal with swathes of added regulation and financial work that these types of mergers create and that can only come from the contracting market.”